Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.7 |
mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.061 | 0.7 |